Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05568420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 2026 → Sep 2027
Enrollment reduced 74% 160 → 41 participants
See other at-risk trials from Memorial Sloan Kettering Cancer Center

Record History

  1. Primary and study completion pushed from Sep 2026 to Sep 2027 Enrollment reduced: 160 → 41 participants · Enrollment closed, study ongoing · Site details revisedv7 Show 3 more changesShow less
    • Enrollment reduced: 160 → 41 participants
    • Enrollment closed, study ongoing
    • Site details revised
  2. Primary and study completion dates: Sep 2025 to Sep 2026v6
  3. Eligibility criteria expanded, about 16 words Collaborators expanded, about 9 wordsv5 Show 1 more changeShow less
    • Collaborators expanded, about 9 words

    See this version in full on ClinicalTrials.gov ↗

  4. Eligibility criteria expanded, about 4 wordsv4 See this version in full on ClinicalTrials.gov ↗
  5. Eligibility criteria expanded, about 26 wordsv3 See this version in full on ClinicalTrials.gov ↗
  6. Eligibility criteria expanded, about 12 wordsv2 See this version in full on ClinicalTrials.gov ↗
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will collect biospecimens (including blood, tissue, and stool samples) and health information to create a database-a type of collection of information-for better understanding young onset colorectal cancer (YOCRC). The study will include both people with YOCRC and healthy people.
Trial Details
NCT Number NCT05568420
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Shaare Zedek Medical Center, Technion, Israel Institute of Technology
Conditions Colorectal Cancer
Enrollment 41 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov